LAIYANG, China, June 30, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China ("China"), today announced that it held its 2011 Annual Meeting of Stockholders (the ''Annual Meeting'') on June 28, 2011 in Laiyang City, Shandong Province, PRC.
At the Annual Meeting, the Company's stockholders were asked to vote on a proposal to elect five directors to serve until the Company's 2012 Annual Meeting of Stockholders and until their successors are duly elected and qualified. Mr. Wubo Cao, Mr. Xiaowei Feng, Ms. Lei Huang, Mr. Jian Ge and Mr. George Zhou were elected as members of the Board of Directors of the Company at the Annual Meeting.
The stockholders also ratified the appointment of Marcum Bernstein & Pinchuk LLP as the Company's independent registered public accountants for the fiscal year ending June 30, 2011 at the Annual Meeting.
At the Annual Meeting, the Company's stockholders also approved and adopted the Jiangbo Pharmaceuticals, Inc. 2011 Omnibus Securities and Incentive Plan.
About Jiangbo Pharmaceuticals, Inc.
Jiangbo is engaged in the research, development, production, marketing and sales of pharmaceutical products in China. The Company's operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong Province. Jiangbo produces both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. For additional information, please visit the Company's website (www.jiangbopharma.com).
Jiangbo Pharmaceuticals, Inc.
Mr. Jin Linxian,CEO
SOURCE Jiangbo Pharmaceuticals, Inc.